AOD-9604Q, a synthetic fragment of human growth hormone (hGH), has emerged as a novel therapeutic candidate for addressing various musculoskeletal disorders. Its specific mechanism of action involves binding with the growth hormone receptor, primarily stimulating collagen synthesis and promoting bone density. Preclinical studies have demonstrated